Open Access
Table IV
Pain assessment in evaluated studies.
| Study | Intervention | Method of intervention | Follow up | Results | Statistical significance | ||
|---|---|---|---|---|---|---|---|
| Test group | Control group | Test group | Control group | ||||
| Sáez-Alcaide et al., 2020 [15] | A topical gel of chitosan, 0.2% chlorhexidine, allantoin, and dexpanthenol. | Placebo gel included all the components of the commercially available gel except chitosan, 0.2% chlorhexidine, allantoin, and dexpanthenol. | 10-cm VAS score | 48 hours and 7 days | 2.56±1.19 | 3.25±1.6 | p = 0.002 |
| Pippi et al., 2016 [18] | HDD | Haemostatic sponge | 0-10 subjective scale (Pain Score) | An evening of surgery (PS T1) and the next morning over the phone (PS T2) and 5 ±1 days after at the moment of suture removal (PS T3). | PS T1 (2.55 ± 2.16) PS T2 (1.10 ± 1.94) PS T3 (0) |
PS T1 (2.30 ± 2.25) PS T2 (1.60 ± 1.90) PS T3 (0.30 ± 0.65) |
PS T1 (p = 0.7263) PS T2 (p = 0.3843) PS T3 (p < 0.05) |
| Lope- Lopez et al., 2015 [16] | Gel containing chlorhexidine, dexpanthenol, allantoin and chitosan (BP) gel | BC oral rinse | 10-cm VAS score | 6 hours and 7 days | 6.5±1.2 | 6.5±1.3 | p = 0.0001 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.